References
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874
Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452–3455
Bone RC (1993) Gram-negative sepsis: a dilemma of modern medicine. Clin Mibrobiol Rev 6:57–68
Matuschak G, Rinaldo J (1988) Organ interactions in the ARDS during sepsis. Role of the liver in host defense. Chest 94:401–406
Welbourn CRB, Young Y (1992) Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg 79:998–1003
Parrilo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471–1477
Cipolle MD, Pasquale MD, Cerra FB (1993) Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin 9:261–298
Strieter RM, Lynch JP, Basha MA, Standiford TJ, Kasahara K, Kunkel SL (1990) Host responses in mediating sepsis and adult respiratory distress syndrome. Semin Respir Infect 5:233–247
Manthous CA, Hall JB, Samsel RW (1993) Endotoxin in human disease. Part 1. Biochemistry, assay and possible role in diverse disease states. Chest 104:1572–1581
Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:2634
Gardinali M, Padalino P, Vesconi S et al (1992) Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg 127(10): 1219–1224
Monick M, Glazier J, Hunninghake GW (1987) Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2. Am Rev Respir Dis 135:72–77
Manthous CA, Hall JB, Samsel RW (1993) Endotoxin in human disease. Part 2. Biologic effects and clinical evaluations of antiendotoxin therapies. Chest 104:1872–1881
Bruin KF, von der Möhlen MAM, van Deventer SJH (1994) Endotoxemia and sepsis: important roles for lipopolysaccharides, binding proteins and CD 14 in endotoxin signal transduction. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis. Current perspectives in pathophysiology and therapy. Springer. Berlin, pp 53–60
Kirikae T, Lei MG, Chen TY, Morrison DC (1994) Interactions of endotoxin with membranes and membrane receptors. In: Brigham K (ed) Endotoxin and the lungs. Marcel Dekker, New York, pp 21–44
Martin TR, Tobias PS, Mathison JC, Ulevitch RJ (1994) Interactions between endotoxin and endotoxin-binding protein. In: Brigham K (ed) Endotoxin and the lungs. Marcel Dekker, New York, pp 45–67
Schumann RR, Lamping N, Kirschning C, Knopf HP, Hoess A, Hermann F (1994) Lipopolysaccharide binding proteins: its role and therapeutical potential in inflammation and sepsis. Biochem Soc Trans 22:80–83
Tracey KJ, Cerami A (1993) Tumor necrosis factor: an update review of its biology. Crit Care Med 21:S415-S422
Beutler B, Grau GE (1993) Tumor necrosis factor in the pathogenesis of infectious disease. Crit Care Med 21: S423-S435
Dunn DL (1991) Role of endotoxin and host cytokines in septic shock. Chest 100:164S-168S
Ghosh S, Latimer R, Gray BM, Harwood RJ, Oduro A (1993) Endotoxin-induced organ injury. Crit Care Med 21:S19-S24
Marks JD, Marks CB, Luce JM et al (1990) Plasma tumor necrosis factor in patients with septic shock. Am Rev Respir Dis 141:94–97
Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975–978
Dinarello CA, Gelfand JA, Wolff SM (1993) Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 269: 1829–1835
de Wall J, Malefyt R, Abrams J, Bennett B, Figdor CC, de Vries JE (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulary role for IL-10 produced by monocytes. J Exp Med 174:1209–1220
Marchant A, Devière J, Byl B, De Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicaemia. Lancet 343:707–708
Exley AR, Cohen J, Buurman W et al (1990) Monoclonal antibody to TNF in severe septic shock. Lancet 335: 1275–1277
Fisher CJ, Opal SM, Dhainaut JF et al (1993) Influence of an anti-tumor necrosis monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318–327
Fisher CJ Jr, Slotman GJ, Opal SM et al (1994) Ihitial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of septic syndrome: a randomized, open-label, placebo-controlled, multicenter trial. Crit Care Med 22:12–21
Mantovani A, Bussolino F, Dejana E (1992) Cytokines regulation of endothelial cell function. FASEB J 6: 2591–2599
Osborn L (1990) Leukocyte adhesion to endothelium in inflammation. Cells 62:3–6
Gee MH, Albertine KH (1993) Neutrophil-endothelial cell interactions in the lung. Ann Rev Physiol 55:227–248
Malik AB (1993) Endothelial cell interactions and integrins. New Horizons 1:37–51
Adams DH, Shaw S (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343: 831–836
Kilbourn RG, Belloni P (1990) Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Nath Cancer Inst 82:772–776
Vallance P, Moncada S (1993) Role of endogenous nitric oxide in septic shock. New Horizons 1:77–86
Moncada S, Palmer R, Higgs E (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–142
Ochoa JB, Udekura OA, Billiar TR et al (1991) Nitrogen oxide levels in patients following trauma and during sepsis. Ann Surg 214:621–626
Lorente JA, Landin L, De Pablo R et al (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295
Anggard E (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343:1199–1206
Freeman B (1994) Free radical chemistry of nitric oxide. Looking at the dark side. Chest 105:79S-84S
Klebanoff SJ (1988) Phagocytic cells: products of oxygen metabolism. In: Gallin JI, Goldstein JM, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Raven Press, New York, pp 391–444
Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–375
Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93–99
Ward PA (1991) Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils. Am J Med 91 [Suppl 3 c]:89S-94S
Zimmerman JJ (1992) Oxyradical pathogenesis in sepsis. Mediators of sepsis. In: Lamy M, Thys LG (eds) Update in intensive care and emergency medicine, vol 16. Springer, Berlin, pp 136–151
Kretzschmar M (1994) Role of oxygen free radicals in the pathophysiology of sepsis. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis. Current perspectives in pathophysiology and therapy. Springer, Berlin, pp 122–135
Goode HF, Webster NR (1993) Free radicals and antioxidants in sepsis. Crit Care Med 21:1770–1776
Nahum A, Chamberlin W, Sznajder JI (1991) Differential activation of mixed venous and arterial neutrophils in patients with sepsis syndrome and acute lung injury. Am Rev Respir Dis 143:1083–1087
Sznajder JL, Fraiman A, Hall JB et al (1989) Increased hydrogen peroxide in the expired breath of patients with acute hypoxemia respiratory failure. Chest 96:606–612
Bertrand Y, Pincemail J, Hannique G et al (1989) Differences in tocopherol-lipid ratio in ARDS and no ARDS patients. Intensive Care Med 15:87–93
Pacht ER, Timerman AP, Lykens MG, Merola AJ (1991) Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100:1397–1403
Leff JA, Parsons PE, Day CE et al (1993) Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis. Lancet 341: 777–780
Levi M, Ten Cate H, van der Poll T, van Deventer SJH (1993) Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270:975–979
Koltai M, Hosford D, Braquet P (1993) Platelet-activating factor in septic shock. New Horizons 1:87–95
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lamy, M., Deby-Dupont, G. Is sepsis a mediator-inhibitor mismatch?. Intensive Care Med 21 (Suppl 2), S250–S257 (1995). https://doi.org/10.1007/BF01740763
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01740763